<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2125">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01925677</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00055955</org_study_id>
    <nct_id>NCT01925677</nct_id>
  </id_info>
  <brief_title>Robotic Single Port Donor Nephrectomy</brief_title>
  <official_title>Use of the Intuitive Surgical da Vinci® Single-Site™ With Instruments and Accessories for Single-Port Laparoscopic Nephrectomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Maryland, Baltimore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility study on robotic-assisted single-site donor nephrectomy utilizing da Vinci&#xD;
      instrumentation and Single-Site platforms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our center has performed over 200 single-port donor nephrectomies with standard laparoscopy&#xD;
      and has reported patient benefits associated with a single port approach. The single port&#xD;
      robotic platform offers the potential to ameliorate the significant technical and ergonomic&#xD;
      challenges that currently limit more widespread application of single port donor surgery.&#xD;
      After being informed of the potential risks and off-label use of the da Vinci Single-Site&#xD;
      approach in our study, patients will undergo a robotic-assisted single-site donor nephrectomy&#xD;
      performed by a two-surgeon team utilizing existing da Vinci instrumentation and Single-Site&#xD;
      platforms. Renal mobilization and vascular dissection will be performed with manual&#xD;
      laparoscopy performed for vascular division utilizing stapling devices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful Completion of the Surgical Procedure</measure>
    <time_frame>during operation</time_frame>
    <description>The primary objective is to determine the feasibility measure of the current Single-Site platform to perform donor nephrectomy prior to vascular division and extraction. Specifically, it will be recorded which portions of the operation utilized the robotic device. The primary outcome variable is the completion of the operation for kidney donation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative Times</measure>
    <time_frame>during operation</time_frame>
    <description>Operative times will closely be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>during operation</time_frame>
    <description>Blood loss of patients will be closely monitored and recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.</measure>
    <time_frame>intra-operative experience collected within 24 hours</time_frame>
    <description>A surgeon ergonomics questionnaire will be given to surgeons after performing both robotic assisted and standard laparoscopic single port donor nephrectomies. The results from both of these surveys will then be compared. These are qualitative and were not analyzed for statistical trends.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Renal Transplant Donor of Left Kidney</condition>
  <condition>Donor Nephrectomy</condition>
  <condition>Robotic Surgery</condition>
  <condition>Single-port</condition>
  <arm_group>
    <arm_group_label>da Vinci® Single-Site™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Robotic-assisted single-incision laparoscopic nephrectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>da Vinci® Single-Site™</intervention_name>
    <description>Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
    <arm_group_label>da Vinci® Single-Site™</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must be approved by the Living Donor Center.&#xD;
&#xD;
          -  Patient must have compatible blood type with the recipient.&#xD;
&#xD;
          -  Patient must have body mass index less than 35.&#xD;
&#xD;
          -  Patient must have appropriate anatomy for left kidney donation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any patient receiving anticoagulant drugs such as Coumadin or warfin&#xD;
&#xD;
          -  Any patient suffering from an active urinary tract infections&#xD;
&#xD;
          -  Any patients suffering from cancer.&#xD;
&#xD;
          -  Any patients suffering from diabetes.&#xD;
&#xD;
          -  Any patients suffering from kidney disease.&#xD;
&#xD;
          -  Any patients suffering from heart disease.&#xD;
&#xD;
          -  Any patients suffering from liver disease.&#xD;
&#xD;
          -  Any patients suffering from HIV or hepatitis&#xD;
&#xD;
          -  Any patients suffering from previous major abdominal surgery.&#xD;
&#xD;
          -  Any patients suffering from more than two left renal arteries.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rolf N Barth, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, Baltimore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Barth RN, Phelan MW, Goldschen L, Munivenkatappa RB, Jacobs SC, Bartlett ST, Philosophe B. Single-port donor nephrectomy provides improved patient satisfaction and equivalent outcomes. Ann Surg. 2013 Mar;257(3):527-33. doi: 10.1097/SLA.0b013e318262ddd6.</citation>
    <PMID>22968070</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 6, 2013</study_first_submitted>
  <study_first_submitted_qc>August 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2013</study_first_posted>
  <results_first_submitted>May 15, 2019</results_first_submitted>
  <results_first_submitted_qc>November 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 20, 2019</results_first_posted>
  <last_update_submitted>November 1, 2019</last_update_submitted>
  <last_update_submitted_qc>November 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland, Baltimore</investigator_affiliation>
    <investigator_full_name>Rolf Barth</investigator_full_name>
    <investigator_title>Director of Liver Transplantation</investigator_title>
  </responsible_party>
  <keyword>Transplant</keyword>
  <keyword>donor</keyword>
  <keyword>nephrectomy</keyword>
  <keyword>robotic</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>single-port</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 5, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT01925677/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>da Vinci® Single-Site™</title>
          <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>da Vinci® Single-Site™</title>
          <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" lower_limit="42" upper_limit="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of participants</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Successful Completion of the Surgical Procedure</title>
        <description>The primary objective is to determine the feasibility measure of the current Single-Site platform to perform donor nephrectomy prior to vascular division and extraction. Specifically, it will be recorded which portions of the operation utilized the robotic device. The primary outcome variable is the completion of the operation for kidney donation.</description>
        <time_frame>during operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>da Vinci® Single-Site™</title>
            <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
          </group>
        </group_list>
        <measure>
          <title>Successful Completion of the Surgical Procedure</title>
          <description>The primary objective is to determine the feasibility measure of the current Single-Site platform to perform donor nephrectomy prior to vascular division and extraction. Specifically, it will be recorded which portions of the operation utilized the robotic device. The primary outcome variable is the completion of the operation for kidney donation.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Times</title>
        <description>Operative times will closely be measured</description>
        <time_frame>during operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>da Vinci® Single-Site™</title>
            <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Times</title>
          <description>Operative times will closely be measured</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Loss</title>
        <description>Blood loss of patients will be closely monitored and recorded.</description>
        <time_frame>during operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>da Vinci® Single-Site™</title>
            <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Loss</title>
          <description>Blood loss of patients will be closely monitored and recorded.</description>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77" spread="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.</title>
        <description>A surgeon ergonomics questionnaire will be given to surgeons after performing both robotic assisted and standard laparoscopic single port donor nephrectomies. The results from both of these surveys will then be compared. These are qualitative and were not analyzed for statistical trends.</description>
        <time_frame>intra-operative experience collected within 24 hours</time_frame>
        <population>surgeon questionnaire</population>
        <group_list>
          <group group_id="O1">
            <title>da Vinci® Single-Site™</title>
            <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
          </group>
        </group_list>
        <measure>
          <title>The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.</title>
          <description>A surgeon ergonomics questionnaire will be given to surgeons after performing both robotic assisted and standard laparoscopic single port donor nephrectomies. The results from both of these surveys will then be compared. These are qualitative and were not analyzed for statistical trends.</description>
          <population>surgeon questionnaire</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data was collected for 1 year from time of surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>da Vinci® Single-Site™</title>
          <description>Robotic-assisted single-incision laparoscopic nephrectomy.&#xD;
da Vinci® Single-Site™: Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Rolf Barth</name_or_title>
      <organization>University of Maryland, Baltimore</organization>
      <phone>4103286020 ext 4103286020</phone>
      <email>rnbarth@som.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

